21 Jan 20208cites
A Phase IIa Clinical Trial of 2-Iminobiotin for the Treatment of Birth Asphyxia in DR Congo, a Low-Income CountryPublisher sitePediatric Drugs, Neonatal and fetal brain pathology
Active, last published 2026
In neonatal respiratory health research
Jephté
Bambi
Scholar“Research focused on Neonatal Respiratory Health Research and adjacent fields.”
Université de Kinshasa (UNIKIN)
DR Congo
Claim Your ProfileDR Congo2
H-index
14
Citations
Jephté has not officially claimed their profile. If you are Jephté, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ephté Bambi is a researcher working on Neonatal Respiratory Health Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Jephté's work has been cited 14 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Neonatal Respiratory Health Research×4Neonatal and fetal brain pathology×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Kinshasa, DR CongoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works9 Feb 2018Open access5cites
Observational study shows that it is feasible to provide neuroprotective treatment for neonatal encephalopathy in low‐income countriesPublisher siteActa Paediatrica, Neonatal and fetal brain pathology
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Jephté?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you